|
→ |
|
Demand for
Insulin Delivery technologies that work is rising |
|
→ |
|
Effectiveness
of traditional insulin treatment showing decline with
increasing Diabetic population |
|
→ |
|
Type II diabetes therapy
market is expected to exceed US $15.3 Billion by 2013 |
|
→ |
|
Oral dosing is currently under
clinical trials with Insulin inhalers reaching the market in
2007 |
|
→ |
|
VitalCare
Technology Enterprises’ Clinical, Medical, Scientific and
Executive leaders are poised to create a new standard of care
for the treatment of both Type I and Type II diabetes.
|
|
→ |
|
VitalCare
signs strategic partnership with CAT Clinics, LLC, BIONICA
International, Inc, & MedEdCo, LLC
to market, sell, license and
open Corporately
owned CAT Clinics. |
| |
|
|
|
Press - VitalCare In The News |
| |
|
→ |
|
VitalCare
Technology Enterprises is established for development of
Intercellular Activation Therapy Diabetes Centers, affiliated
with CAT Clinics, LLC, BIONICA International and MedEdCo
Corporation.
|
|
→ |
|
“Stock Exchange” Agreements signed between VitalCare
Technology, CAT Clinics, LLC, and MedEdCo Corporation, providing
a co-ownership relationship between the three companies for the
purpose of promotion and expansion of the iCAT Diabetes Center
business opportunity Licensing Agreement Signed between
VitalCare Technology and CAT Clinics, LLC and BIONICA
International. |
|
→ |
|
Management Service Agreement
signed between VitalCare Technology and MedEdCo Corporation for
ongoing clinical support, professional education and
credentialing, and quality assurance services. |
|
→ |
|
Setup and implement the Company
Website at
www.vitalcaretechnology.com Internet
Link established between VitalCare Technology’s website at
www.vitalcaretechnology.com and
www.diabetes.net (Mr. Gregory
Gilbert’s website) used to promote Intercellular Activation
Therapy.
|
| |
|
What
Patients Are Saying:
|
|
→ |
|
In
addition to published research articles in peer reviewed
journals featuring iCAT therapy’s clinical success the Company
will use its patient testimonials concerning the life-changing
benefits they received from iCAT therapy as in the following
documented patient testimonials: |
|
→ |
|
“My neuropathy didn’t allow me to sleep at night. I was in
constant pain from the knees down. My husband couldn’t sleep and
nothing helped. After several weeks of Cellular Activation
Therapy, I noticed changes. Now I take no pain medication at all
and have no twinges.” (54, white, woman 28 years Type 1 on iCAT
therapy for 8 years) |
|
→ |
|
“
I am now independent and can go anywhere. I had severe
cardiac myopathy. Since I have been on the program, I have
lowered my insulin from 150 units per day to 24 units daily. It
worked after 3 weeks. I have more energy; before, I slept all
the time. I now have a very active life.” (53-year-old woman on
a heart transplant list for 3 years; on iCAT therapy for 5
years.) |
|
→ |
|
The
youngest person ever to be treated with iCAT therapy to date
started treatments at age 5. Today that little girls of 5 has
attained the age of 32 and has become a mother for the third
time. Her pregnancies were without any hypoglycemic events or
hypertension, throughout each trimester, as she continued on
iCAT therapy utilizing the in-home therapy protocol. As the
first of the homecare test patients, she delivered healthy
normal babies at full term without one side effect or
complication and to date has never had any complications or side
effects to iCAT therapy. Her picture can be seen on the
“portal” website at:
www.diabetes.net.
|
|
Back>> |
